Craft

Advanced
  • Home
  •  / Genetic Signatures
Genetic Signatures

Genetic Signatures

Stock Price

$0.6

2024-10-04

Market Capitalization

$136.1 M

2024-10-04

Revenue

$15.9 M

FY, 2025

Genetic Signatures Summary

Company Summary

Overview
Genetic Signatures is a molecular diagnostic company focused on the development and commercialization of its proprietary 3base platform technology. It provides hospital and pathology laboratories with the molecular tools to screen for a range of infectious pathogens.
Type
Public
Status
Active
Founded
2001
HQ
Newtown, AU | view all locations
Website
https://geneticsignatures.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Table of Contents

Key People

  • Doug Millar

    Doug Millar, Chief Scientific Officer

    • John Buckels

      John Buckels, Director of Sales and Support Europe

      • Neil Gunn

        Neil Gunn, Non-Executive Director

        LocationsView all

        1 location detected

        • Newtown, NSW HQ

          Australia

          7 Eliza St

        Genetic Signatures Financials

        Summary Financials

        Revenue (H1, 2026)
        $8.7M
        Gross profit (H1, 2026)
        $6.8M
        Net income (H1, 2026)
        ($6.4M)
        Cash (H1, 2026)
        $17.2M
        EBIT (H1, 2026)
        ($6.9M)

        Competitors and Similar Companies

        Compare competitors

        Footer menu

        Product

        Solutions

        Resources

        Company

        © Craft.co 2026
        Share price data provided by IEX